Inherited SHQ1 mutations impair interaction with NAP57/dyskerin, a major target in dyskeratosis congenita

Jonathan Bizarro, U. Thomas Meier

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: The inherited bone marrow failure syndrome dyskeratosis congenita (DC) is most frequently caused by mutations in DKC1 (MIM# 300126), the gene encoding NAP57 (aka dyskerin). The typically missense mutations modulate the interaction of NAP57 with its chaperone SHQ1, but no DC mutations have been identified in SHQ1 (MIM# 613663). Here, we report on two compound heterozygous mutations in SHQ1 in a patient with a severe neurological disorder including cerebellar degeneration. Methods: The SHQ1 mutations were identified by patient exome sequencing. The impact of the mutations was assessed in pulldown assays with recombinant NAP57. Results: The SHQ1 mutations were the only set of mutations consistent with an autosomal recessive mode of inheritance. The mutations map to the SHQ1-NAP57 interface and impair the interaction of the recombinant SHQ1 variants with NAP57. Conclusion: Intrauterine growth retardation and the neurological phenotype of the patient are reminiscent of the severe clinical variant of DC, the Hoyeraal-Hreidarsson syndrome (HH). Hence, SHQ1 screening may be warranted in patients with inherited bone marrow failure syndromes.

Original languageEnglish (US)
Pages (from-to)805-808
Number of pages4
JournalMolecular Genetics and Genomic Medicine
Volume5
Issue number6
DOIs
StatePublished - Jan 1 2017

Fingerprint

Dyskeratosis Congenita
Mutation
Exome
Fetal Growth Retardation
NAP57
Missense Mutation
Nervous System Diseases
Phenotype

Keywords

  • compound heterozygous mutations
  • dyskeratosis congenita
  • H/ACA RNP
  • Hoyeraal-Hreidarsson syndrome
  • protein-protein interaction
  • ribonucleoprotein (RNP) biogenesis

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Molecular Biology
  • Medicine(all)

Cite this

Inherited SHQ1 mutations impair interaction with NAP57/dyskerin, a major target in dyskeratosis congenita. / Bizarro, Jonathan; Meier, U. Thomas.

In: Molecular Genetics and Genomic Medicine, Vol. 5, No. 6, 01.01.2017, p. 805-808.

Research output: Contribution to journalArticle

@article{4f9a0af0061b42aea5622e408413bce7,
title = "Inherited SHQ1 mutations impair interaction with NAP57/dyskerin, a major target in dyskeratosis congenita",
abstract = "Background: The inherited bone marrow failure syndrome dyskeratosis congenita (DC) is most frequently caused by mutations in DKC1 (MIM# 300126), the gene encoding NAP57 (aka dyskerin). The typically missense mutations modulate the interaction of NAP57 with its chaperone SHQ1, but no DC mutations have been identified in SHQ1 (MIM# 613663). Here, we report on two compound heterozygous mutations in SHQ1 in a patient with a severe neurological disorder including cerebellar degeneration. Methods: The SHQ1 mutations were identified by patient exome sequencing. The impact of the mutations was assessed in pulldown assays with recombinant NAP57. Results: The SHQ1 mutations were the only set of mutations consistent with an autosomal recessive mode of inheritance. The mutations map to the SHQ1-NAP57 interface and impair the interaction of the recombinant SHQ1 variants with NAP57. Conclusion: Intrauterine growth retardation and the neurological phenotype of the patient are reminiscent of the severe clinical variant of DC, the Hoyeraal-Hreidarsson syndrome (HH). Hence, SHQ1 screening may be warranted in patients with inherited bone marrow failure syndromes.",
keywords = "compound heterozygous mutations, dyskeratosis congenita, H/ACA RNP, Hoyeraal-Hreidarsson syndrome, protein-protein interaction, ribonucleoprotein (RNP) biogenesis",
author = "Jonathan Bizarro and Meier, {U. Thomas}",
year = "2017",
month = "1",
day = "1",
doi = "10.1002/mgg3.314",
language = "English (US)",
volume = "5",
pages = "805--808",
journal = "Molecular genetics & genomic medicine",
issn = "2324-9269",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Inherited SHQ1 mutations impair interaction with NAP57/dyskerin, a major target in dyskeratosis congenita

AU - Bizarro, Jonathan

AU - Meier, U. Thomas

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Background: The inherited bone marrow failure syndrome dyskeratosis congenita (DC) is most frequently caused by mutations in DKC1 (MIM# 300126), the gene encoding NAP57 (aka dyskerin). The typically missense mutations modulate the interaction of NAP57 with its chaperone SHQ1, but no DC mutations have been identified in SHQ1 (MIM# 613663). Here, we report on two compound heterozygous mutations in SHQ1 in a patient with a severe neurological disorder including cerebellar degeneration. Methods: The SHQ1 mutations were identified by patient exome sequencing. The impact of the mutations was assessed in pulldown assays with recombinant NAP57. Results: The SHQ1 mutations were the only set of mutations consistent with an autosomal recessive mode of inheritance. The mutations map to the SHQ1-NAP57 interface and impair the interaction of the recombinant SHQ1 variants with NAP57. Conclusion: Intrauterine growth retardation and the neurological phenotype of the patient are reminiscent of the severe clinical variant of DC, the Hoyeraal-Hreidarsson syndrome (HH). Hence, SHQ1 screening may be warranted in patients with inherited bone marrow failure syndromes.

AB - Background: The inherited bone marrow failure syndrome dyskeratosis congenita (DC) is most frequently caused by mutations in DKC1 (MIM# 300126), the gene encoding NAP57 (aka dyskerin). The typically missense mutations modulate the interaction of NAP57 with its chaperone SHQ1, but no DC mutations have been identified in SHQ1 (MIM# 613663). Here, we report on two compound heterozygous mutations in SHQ1 in a patient with a severe neurological disorder including cerebellar degeneration. Methods: The SHQ1 mutations were identified by patient exome sequencing. The impact of the mutations was assessed in pulldown assays with recombinant NAP57. Results: The SHQ1 mutations were the only set of mutations consistent with an autosomal recessive mode of inheritance. The mutations map to the SHQ1-NAP57 interface and impair the interaction of the recombinant SHQ1 variants with NAP57. Conclusion: Intrauterine growth retardation and the neurological phenotype of the patient are reminiscent of the severe clinical variant of DC, the Hoyeraal-Hreidarsson syndrome (HH). Hence, SHQ1 screening may be warranted in patients with inherited bone marrow failure syndromes.

KW - compound heterozygous mutations

KW - dyskeratosis congenita

KW - H/ACA RNP

KW - Hoyeraal-Hreidarsson syndrome

KW - protein-protein interaction

KW - ribonucleoprotein (RNP) biogenesis

UR - http://www.scopus.com/inward/record.url?scp=85040651543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040651543&partnerID=8YFLogxK

U2 - 10.1002/mgg3.314

DO - 10.1002/mgg3.314

M3 - Article

VL - 5

SP - 805

EP - 808

JO - Molecular genetics & genomic medicine

JF - Molecular genetics & genomic medicine

SN - 2324-9269

IS - 6

ER -